Announcements Trials
Browse Landscape

Status

Recruiting 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1Carcinoma 1

Interventions

Observation 23Blood Specimen Collection 20Drug Therapy 14Surveys and Questionnaires 10Surgical Procedures, Operative 8Immune Checkpoint Inhibitors 8Immunotherapy 7Positron Emission Tomography Computed Tomography 5Hematologic Tests 5Watchful Waiting 4Neoadjuvant Therapy 4Fluorodeoxyglucose F18 4Bevacizumab 4tislelizumab 3envafolimab 3darolutamide 3Tyrosine Kinase Inhibitors 3Therapeutics 3Standard of Care 3Radiotherapy 3Letrozole 3Indocyanine Green 3Imatinib Mesylate 3Endosonography 3Endoscopic Mucosal Resection 3Docetaxel 3Cyclophosphamide 3Capecitabine 3Artificial Intelligence 3pertuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Observational × donafenib × Clear all
NCT07180459 2025-09-18

The Treatment of Unresectable Liver Cancer With E-TACE Combined With Donafenib:A Prospective, Single-arm, Multicenter, Observational Study

The First Affiliated Hospital of Zhengzhou University

Not yet recruiting
118 enrolled
Gastrointestinal

Carcinoma, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡